306 Appendices 371. Nicholson AG, Tsao MS, Beasley MB, et al. The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015. J Thorac Oncol. 2022;17(3):362-387. doi:10.1016/j. jtho.2021.11.003 372. Baine M, Beasley MB, Buonocore. The distinction between spread through air spaces (STAS) and artifacts in selected images is highly reproducible. Mod Pathol. 2020;(33):S1754-S1755. 373. Karasaki T, Moore DA, Veeriah S, et al. Evolutionary characterization of lung adenocarcinoma morphology in TRACERx. Nat Med. 2023;29(April). doi:10.1038/s41591-023-02230-w 374. Khalbuss WE, Yang H, Lian Q, Elhosseiny A, Pantanowitz L, Monaco SE. The cytomorphologic spectrum of small-cell carcinoma and large-cell neuroendocrine carcinoma in body cavity effusions: A study of 68 cases. Cytojournal. 2011;8:18. doi:10.4103/1742-6413.86816 375. Kim L, Choi SJ, Park IS, Han JY, Kim JM, Chu YC. Cytomorphologic features of small cell carcinoma of lung in effusion fluid using a liquid-based cytology technique. Diagn Cytopathol. 2020;48(3):203-210. doi:10.1002/dc.24365 376. Kakinuma H, Mikami T, Iwabuchi K, et al. Diagnostic findings of bronchial brush cytology for pulmonary large cell neuroendocrine carcinomas: Comparison with poorly differentiated adenocarcinomas, squamous cell carcinomas, and small cell carcinomas. Cancer. 2003;99(4):247-254. doi:10.1002/cncr.11220 377. Sun L, Sakurai S, Sano T, Hironaka M, Kawashima O, Nakajima T. High-grade neuroendocrine carcinoma of the lung: Comparative clinicopathological study of large cell neuroendocrine carcinoma and small cell lung carcinoma: Original Article. Pathol Int. 2009;59(8):522-529. doi:10.1111/j.1440-1827.2009.02402.x 378. Huang CC, Collins BT, Flint A, Michael CW. Pulmonary neuroendocrine tumors: An entity in search of cytologic criteria. Diagn Cytopathol. 2013;41(8):689-696. doi:10.1002/dc.22933 379. Crapanzano JP, Loukeris K, Borczuk AC, Saqi A. Cytological, histological, and immunohistochemical findings of pulmonary carcinomas with basaloid features. Diagn Cytopathol. 2011;39(2):92-100. doi:10.1002/dc.21335 380. Tsutani Y, Miyata Y, Mimae T, et al. The prognostic role of pathologic invasive component size, excluding lepidic growth, in stage i lung adenocarcinoma. J Thorac Cardiovasc Surg. 2013;146(3):580-585. doi:10.1016/j.jtcvs.2013.04.032 381. Yoshizawa A, Motoi N, Riely GJ, et al. Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases. Mod Pathol. 2011;24(5):653-664. doi:10.1038/ modpathol.2010.232 382. Aida S, Shimazaki H, Sato K, et al. Prognostic analysis of pulmonary adenocarcinoma subclassification with special consideration of papillary and bronchioloalveolar types. Histopathology. Published online 2004:468-476. 383. Warth A, Muley T, Meister M, et al. The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival. J Clin Oncol. 2012;30(13):1438-1446. doi:10.1200/JCO.2011.37.2185 384. Borczuk AC, Qian F, Kazeros A, et al. Invasive size is an independent predictor of survival in pulmonary adenocarcinoma. Am J Surg Pathol. 2009;33(3):462-469. doi:10.1097/ PAS.0b013e318190157c 385. Chang JC, Alex D, Bott MJ, et al. Comprehensive Next-Generation Sequencing Unambiguously Distinguishes Separate Primary Lung Carcinomas From Intrapulmonary Metastases: Comparison with Standard Histopathologic Approach. Clin Cancer Res. 2019;25(23):7113-7125. doi:10.1158/1078-0432.CCR-19-1700.Comprehensive 386. Mizuuchi H, Suda K, Kitahara H, et al. Solitary pulmonary metastasis from malignant melanoma of the bulbar conjunctiva presenting as a pulmonary ground glass nodule: Report of a case. Thorac Cancer. 2015;6(1):97-100. doi:10.1111/1759-7714.12124
RkJQdWJsaXNoZXIy MTk4NDMw